The medicinal use of cannabidiol (CBD) in Brazil is evolving, with regulatory changes underway to improve access and safety. While the National Health Surveillance Agency approved CBD for medical use in 2023, challenges remain, including legal ambiguities, high costs, cultural stigma, and a need for better education among healthcare professionals. By September 2025, Brazil aims to refine its regulatory framework, potentially leading to a more accessible CBD market.